Patient-reported disease knowledge and educational needs in Lynch syndrome: Findings of an interactive multidisciplinary patient conference

Hereditary Cancer in Clinical Practice

Volumn 12, Issue 1, 2014, Pages

  Bannon, Sarah A ^a   Mork, Maureen ^a   Vilar, Eduardo ^a   Peterson, Susan K ^a   Lu, Karen ^a   Lynch, Patrick M ^a   Rodriguez Bigas, Miguel A ^a   You, YiQian N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer surveillance; Genetic counseling; Health education; Hereditary nonpolyposis colorectal cancer (HNPCC); Lynch syndrome; Patient education

Indexed keywords

EID: 84893191260     PISSN: 17312302     EISSN: 18974287     Source Type: Journal    
DOI: 10.1186/1897-4287-12-1     Document Type: Article

References (14)

1. Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, Guimbaud R, Buecher B, Bignon YJ, Caron O, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 2011, 305:2304-2310. 10.1001/jama.2011.743, 21642682.
2. Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 2009, 137:1621-1627. 10.1053/j.gastro.2009.07.039, 2767441, 19622357.
3. Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, et al. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst 2012, 104:1363-1372. 10.1093/jnci/djs351, 3529597, 22933731.
4. Capelle LG, Van Grieken NC, Lingsma HF, Steyerberg EW, Klokman WJ, Bruno MJ, Vasen HF, Kuipers EJ. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 2010, 138:487-492. 10.1053/j.gastro.2009.10.051, 19900449.
5. Weissman SM, Bellcross C, Bittner CC, Freivogel ME, Haidle JL, Kaurah P, Leininger A, Palaniappan S, Steenblock K, Vu TM, Daniels MS. Genetic counseling considerations in the evaluation of families for Lynch syndrome-a review. J Genet Couns 2011, 20:5-19. 10.1007/s10897-010-9325-x, 20931355.
6. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006, 296:1507-1517. 10.1001/jama.296.12.1507, 17003399.
7. Evaluation of Genomic Applications in P, Prevention Working G Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009, 11:35-41. 2743612, 19125126, Evaluation of Genomic Applications in P, Prevention Working G.
8. Stoffel EM, Garber JE, Grover S, Russo L, Johnson J, Syngal S. Cancer surveillance is often inadequate in people at high risk for colorectal cancer. J Med Genet 2003, 40:e54. 10.1136/jmg.40.5.e54, 1735467, 12746408.
9. Ketabi Z, Mosgaard BJ, Gerdes AM, Ladelund S, Bernstein IT. Awareness of endometrial cancer risk and compliance with screening in hereditary nonpolyposis colorectal cancer. Obstet Gynecol 2012, 120:1005-1012.
10. Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 2008, 122:2017-2022. 10.1002/ijc.23340, 2936778, 18196574.
11. Battista RN, Blancquaert I, Laberge AM, van Schendel N, Leduc N. Genetics in health care: an overview of current and emerging models. Public Health Genomics 2012, 15:34-45. 10.1159/000328846, 21734357.
12. Hawkins AK, Hayden MR. A grand challenge: providing benefits of clinical genetics to those in need. Genet Med 2011, 13:197-200. 10.1097/GIM.0b013e31820c056e, 21283011.
13. Espenschied CR, MacDonald DJ, Culver JO, Sand S, Hurley K, Banks KC, Weitzel JN, Blazer KR. Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs. J Cancer Educ 2012, 27:467-477. 10.1007/s13187-012-0373-9, 3540105, 22610836.
14. Nolen AL, Putten JV. Action research in education: Addressing gaps in ethical principles and practices. Educational Researcher 2007, 36:401-407.